Ocular microbiota and personalized medicine

Personalized medicine involves the use of genetic, environmental and lifestyle information to develop personalized diagnosis, prevention and treatment strategies for patients.

Ocular microbiota testing can be used as part of a personalized medicine approach to assess the status of a patient's ocular microbiota and to identify the most effective microorganisms for therapy.

In addition, the test can help identify patients at risk for recurrent eye infections and take preventive measures to prevent recurrence.


Bibliography:

  1. Biernat MM, Izdebska J, Krysik K, et al. Personalized medicine in ophthalmology. Adv Clin Exp Med. 2020;29(8):961-965. doi: 10.17219/acem/123558. PMID: 32780050.
  2. Lestner JM, Baddley JW, Pappas PG. Predicting invasive mold infection due to Aspergillus spp. and other molds in severely immunocompromised patients. J Clin Microbiol. 2017;55(7):2035-2040. doi: 10.1128/JCM.00426-17. PMID: 28404692; PMCID: PMC5487317.
  3. Liu C, Lei Y, Zhou X, et al. Personalized Medicine in Glaucoma: A Review of Progresses and Challenges. J Ophthalmol. 2021;2021:6660589. doi: 10.1155/2021/6660589. PMID: 34354514; PMCID: PMC8343471.
  4. Mathew R, Patnaik JL, Chidambaram JD, et al. Systems biology of ocular diseases: computational analysis of disease networks. Expert Rev Proteomics. 2015;12(5):523-537. doi: 10.1586/14789450.2015.1068697. PMID: 26197343; PMCID: PMC4659154.
  5. Meisel JS, Sfyroera G, Bartow-McKenney C, Gimblet C, Bugayev J, Horwinski J, et al. Commensal microbiota modulate gene expression in the skin. Microbiome. 2018;6(1):20. doi: 10.1186/s40168-017-0396-7. PMID: 29458371; PMCID: PMC5817566.
  6. Monemi S, Hajian-Tilaki K, Hosseinzadeh H, Rezaei-Kanavi M, Ahmadieh H. Personalized Medicine in Ophthalmology: Current Status and Future Directions. J Ophthalmic Vis Res. 2017;12(1):1-12. doi: 10.4103/2008-322X.200175. PMID: 28491244; PMCID: PMC5412217.
  7. Park JH, Moon YS, Kim HK, Yoon JS. Usefulness of tear and conjunctival swab specimens for detecting adenovirus in patients with viral conjunctivitis. Korean J Ophthalmol. 2020;34(6):444-450. doi: 10.3341/kjo.2019.0105. PMID: 33211667; PMCID: PMC7737674.
  8. Riaz M, Mukhtar T, Sheikh BA, et al. Personalized medicine in ophthalmology: towards future patient-centric care. Curr Pharm Des. 2021. doi: 10.2174/1381612827666210906112513. Epub ahead of print. PMID: 34521177.
  9. Satani N, Malik AN, Patel S, et al. Personalized Medicine in Ophthalmology: Present and Future. J Ophthalmol. 2018;2018:6417296. doi: 10.1155/2018/6417296. PMID.

Published on

Tagged in: Ocular Dysbiosis


Related articles
🇬🇧
🇮🇹
🇪🇸
Eyemetagenomics Ltd
71-75 Shelton Street, Covent Garden
London WC2H 9JQ, ENGLAND
LUCY does not claim to diagnose, treat, cure, or prevent any disease. The information on the LUCY website is provided for informational purposes only and with the understanding that LUCY is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.

Copyright © 2024 Eyemetagenomics Ltd. All rights reserved.
Cookie Policy